AstraZeneca PLCAZNNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+9.8%
5Y CAGR+17.2%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+9.8%/yr
vs +19.0%/yr prior
5Y CAGR
+17.2%/yr
Recent deceleration
Acceleration
-9.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
7 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $58.74B | +8.6% |
| 2024 | $54.07B | +18.0% |
| 2023 | $45.81B | +3.3% |
| 2022 | $44.35B | +18.5% |
| 2021 | $37.42B | +40.6% |
| 2020 | $26.62B | +9.2% |
| 2019 | $24.38B | +10.4% |
| 2018 | $22.09B | -1.7% |
| 2017 | $22.46B | -2.3% |
| 2016 | $23.00B | - |